LifeScience Biologics
CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information
This integration allows users to visualize and share plasmid information such as maps and sequences within the web-based CDD Vault application. Snap...
April 18, 2022 | News
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it clos...
April 12, 2022 | News
PCR Biosystems launches freeze-dryable reagents for ultra-sensitive PCR diagnostic tests
PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit,...
April 08, 2022 | News
Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US
PRG-1801 is a single domain antibody anti-BCMA CAR-T cell therapy in development for the treatment of relapsed/refractory multiple myeloma that has demonst...
April 07, 2022 | News
Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics
Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...
April 05, 2022 | News
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China
Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics. T...
April 04, 2022 | News
BioVaxys Expands Cancer Vaccine Platform
BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer vaccine platf...
March 31, 2022 | News
Telix Advances Development of Glioblastoma Therapy Program
TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...
March 23, 2022 | News
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...
March 21, 2022 | News
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
Sustainalytics' ESG Risk Ratings evaluate over 14,000 companies across 42 industries worldwide, measuring each company's exposure to industry-specific mate...
March 15, 2022 | News
China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...
March 14, 2022 | News
Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals
These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...
March 13, 2022 | News
Molecular Health collaborates to explore the molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that d...
March 11, 2022 | News
Novavax Announces Launch of Global Vaccine Education Programs
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
March 11, 2022 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
